MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Liang, Xue ^a,b   Liu, Yu ^a   Mei, Shiyue ^a   Zhang, Miaomiao ^a   Xin, Jiaxuan ^a   Zhang, Yuan ^a   Yang, Rongcun ^a,c  

^a NANKAI UNIVERSITY   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 124; MICRORNA 125A 5P; MICRORNA 128; MICRORNA 19A; MICRORNA 22; MICRORNA 24; MICRORNA 351; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN22 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSLATION; TH17 CELL; TUMOR IMMUNITY; ANIMAL; C57BL MOUSE; CELL LINE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; DENDRITIC CELLS; FEMALE; MICE; MICE, INBRED C57BL; MICRORNAS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84926432089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121510     Document Type: Article

References (32)

1. Steinman RM (2012) Decisions about dendritic cells: past, present, and future. Annual review of immunology 30: 1-22. doi: 10.1146/annurev-immunol-100311-102839 PMID: 22136168
2. Dubois B, Bridon JM, Fayette J, Barthélémy C, Banchereau J, Caux C, et al. (1999) Dendritic cells directly modulate B cell growth and differentiation. Journal of leukocyte biology 66: 224-230. PMID: 10449158
3. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. The Journal of experimental medicine 195: 327-333. PMID: 11828007
4. Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nature reviews Cancer. pp. 265-277.
5. Kim R, Emi M, Tanabe K (2006) Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 119: 254-264. PMID: 17005005
6. Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annual review of immunology 25: 267-296. PMID: 17134371
7. Wang S, Yang J, Qian J, Wezeman M, Kwak LW, Yi Q (2006) Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood 107: 2432-2439. PMID: 16291589
8. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nature reviews Genetics 5: 522-531. PMID: 15211354
9. Turner ML, Schnorfeil FM, Brocker T (2011) MicroRNAs regulate dendritic cell differentiation and function. Journal of immunology (Baltimore, Md: 1950) 187: 3911-3917. doi: 10.4049/jimmunol.1101137 PMID: 21969315
10. Chen B, Tang H, Liu X, Liu P, Yang L, Xie X, et al. miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer. Cancer Letters 356: 410-417. doi: 10.1016/j.canlet.2014.09.028 PMID: 25304371
11. Huang Z-P, Wang D-Z miR-22 in cardiac remodeling and disease. Trends in Cardiovascular Medicine 24: 267-272. doi: 10.1016/j.tcm.2014.07.005 PMID: 25218673
12. Feng Y, Huang W, Wani M, Yu X, Ashraf M (2014) Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PloS one. pp. e88685.
13. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 434: 338-345. PMID: 15735639
14. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. PMID: 15652477
15. Xu J, Yue F, Wang J, Chen L, QiW(2015) High glucose inhibits receptor activator of nuclear factor-êB ligand-induced osteoclast differentiation via downregulation of v-ATPase V0 subunit d2 and dendritic cell-specific transmembrane protein. Molecular medicine reports 11: 865-870. doi: 10.3892/mmr. 2014.2807 PMID: 25352342
16. Lin C-C, Liu C-P, Hsieh F-C, Lee C-M, Wang W-S (2014) Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
17. Yang R, Murillo FM, Cui H, Blosser R, Uematsu S, Takeda K, et al. (2004) Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. Journal of virology 78: 11152-11160. PMID: 15452235
18. Li HS, Greeley N, Sugimoto N, Liu Y-J, Watowich SS (2012) miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PloS one 7: e52341. doi: 10.1371/journal.pone.0052341 PMID: 23251709
19. Min S, Liang X, Zhang M, Zhang Y, Mei S, Liu J, et al. (2013) Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways. Journal of immunology (Baltimore, Md: 1950) 190: 2437-2446. doi: 10.4049/jimmunol.1202282 PMID: 23355742
20. Vanden Berghe W, Vermeulen L, De Wilde G, De Bosscher K, Boone E, Haegeman G (2000) Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochemical Pharmacology 60: 1185-1195. PMID: 11007957
21. Huang G, Wang Y, Vogel P, Kanneganti T-D, Otsu K, Chi H (2012) Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nature immunology. pp. 152-161.
22. Yu H, Wu M, Zhao P, Huang Y, Wang W, YinW(2014) Neuroprotective effects of viral overexpression of microRNA-22 in rat and cell models of cerebral ischemia-reperfusion injury. Journal of cellular biochemistry.
23. Jena BP (2008) Porosome: the universal molecular machinery for cell secretion. Molecules and cells 26: 517-529. PMID: 19011361
24. Tanaka T, Narazaki M, Kishimoto T (2012) Therapeutic Targeting of the Interleukin-6 Receptor. Annual Review of Pharmacology and Toxicology 52: 199-219. doi: 10.1146/annurev-pharmtox-010611- 134715 PMID: 21910626
25. Kimura A, Kishimoto T (2010) IL-6: Regulator of Treg/Th17 balance. European Journal of Immunology 40: 1830-1835. doi: 10.1002/eji.201040391 PMID: 20583029
26. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238. PMID: 16648838
27. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science (New York, NY) 327: 291-295. doi: 10.1126/science.1183021 PMID: 20075244
28. Huang G, Shi LZ, Chi H (2009) Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and termination. Cytokine 48: 161-169. doi: 10.1016/j.cyto.2009.08.002 PMID: 19740675
29. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. Journal of immunology (Baltimore, Md: 1950) 166: 3837- 3845. PMID: 11238627
30. LeibundGut-Landmann S, Grosz O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, et al. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630-638. PMID: 17450144
31. Sun WH, Kreisle RA, Phillips AW, Ershler WB (1992) In Vivo and in Vitro Characteristics of Interleukin 6-transfected B16 Melanoma Cells. Cancer Research 52: 5412-5415. PMID: 1394147
32. Nuñ ez S, Saez JJ, Fernandez D, Flores-Santibañez F, Alvarez K, Tejon G, et al. (2013) T helper type 17 cells contribute to anti-tumour immunity and promote the recruitment of T helper type 1 cells to the tumour. Immunology 139: 61-71. doi: 10.1111/imm.12055 PMID: 23278668